Melissa C. Larson

Also affiliated with Mayo Clinic in Florida

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.1Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

Papers

Driven by 35 papers — median percentile 90. Top paper: “The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes”.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0103

N/A

1.8DataRank · unranked

76 citations

Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu +134 more

Prognostic gene expression signature for high-grade serous ovarian cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.05.019

N/A

0.718DataRank · unranked

119 citations

S. Chen, Blake Gilks, C. Wang, S.C.Y. Leung, V. Chow +387 more

Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.102028

N/A

0.301DataRank · unranked

6 citations

Tara M. Davidson, Coriolan Lebreton, Leah A. Marsh, Deandra K. Chetram, Hunter J. Atkinson +14 more

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

UNC Libraries(2020)10.17615/6acv-2x23

N/A

0DataRank · unranked

0 citations

Joellen M. Schildkraut, Ian Tomlinson, Hoda Anton‐Culver, Rebecca Sutphen, Maria Notaridou +27 more

Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100471

N/A

0DataRank · unranked

75 citations

Shrabanti Chowdhury, Hong Wang, Sara R. Savage, Richard G. Ivey, Jacob J. Kennedy +25 more

Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma

Blood Cancer Journal(2021)10.1038/s41408-021-00521-4

N/A

0DataRank · unranked

66 citations

Angelo Famà, Melissa C. Larson, Andrew L. Feldman, José C. Villasboas, Zhi-Zhang Yang +20 more

Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era

American Journal of Hematology(2021)10.1002/ajh.26230

N/A

0DataRank · unranked

24 citations

Melissa C. Larson, Alessia Castellino, Joerg Herrmann, David J. Inwards, Gita Thanarajasingam +10 more

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1817

N/A

0DataRank · unranked

13 citations

Karen McCue, Wei Shi, Sharon E. Johnatty, Jonathan Beesley, Andrew Civitarese +62 more

Vaccination History and Risk of Lymphoma and Its Major Subtypes

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0383

N/A

0DataRank · unranked

4 citations

Melissa C. Larson, Stephen M. Ansell, Carrie A. Thompson, Grzegorz S. Nowakowski, Timothy G. Call +10 more

Aspirin and other nonsteroidal anti‐inflammatory drugs, statins and risk of non‐Hodgkin lymphoma

International Journal of Cancer(2021)10.1002/ijc.33541

N/A

0DataRank · unranked

8 citations

Melissa C. Larson, Carrie A. Thompson, Grzegorz S. Nowakowski, Timothy G. Call, William R. Macon +5 more

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

UNC Libraries(2021)10.17615/zn9f-0969

N/A

0DataRank · unranked

0 citations

Celeste Leigh Pearce, Jennifer Anne Doherty, Hoda Anton‐Culver, Penelope M. Webb, Linda Titus +27 more

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer.

Apollo (University of Cambridge)(2021)10.17863/cam.126709

N/A

0DataRank · unranked

0 citations

Karen McCue, Wei Shi, Sharon E. Johnatty, Jonathan Beesley, Andrew Civitarese +65 more

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study

The Lancet Haematology(2022)10.1016/s2352-3026(22)00033-3

N/A

0DataRank · unranked

64 citations

Melissa C. Larson, Julianne J. Lunde, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang +19 more

Revised MALT‐IPI: A new predictive model that identifies high‐risk patients with extranodal marginal zone lymphoma

American Journal of Hematology(2022)10.1002/ajh.26715

N/A

0DataRank · unranked

26 citations

Isildinha M. Reis, Thomas M. Habermann, Brian K. Link, Catherine Thiéblemont, Annarita Conconi +7 more

Therapy for patients with POD24 follicular lymphoma: Treatment patterns and outcomes from the Lymphoma Epidemiology of Outcomes (LEO) Consortium.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7573

N/A

0DataRank · unranked

1 citations

Melissa C. Larson, Jonathan R Day, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang +15 more

Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response

Scientific Reports(2023)10.1038/s41598-023-27555-x

N/A

0DataRank · unranked

64 citations

Jun Chen, Krista M. Goergen, Melissa C. Larson, Ann L. Oberg, Jvan Casarin +6 more

Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study

Blood Cancer Journal(2023)10.1038/s41408-023-00942-3

N/A

0DataRank · unranked

9 citations

Jennifer Gile, Melissa C. Larson, Kittika Poonsombudlert, Reema Tawfiq, Seth Maliske +14 more

Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas

Hematological Oncology(2023)10.1002/hon.3187

N/A

0DataRank · unranked

5 citations

Kerstin Wenzl, Keenan T. Hartert, Jordan E. Krull, Abigail R. Dropik, Joseph P. Novak +16 more

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.04.011

N/A

0DataRank · unranked

25 citations

Simon G. Coetzee, Jonathan P. Tyrer, Pei-Chen Peng, Will Rosenow, Stephanie Chen +95 more

Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101443

N/A

0DataRank · unranked

11 citations

Kerstin Wenzl, Melissa A. Hopper, Michelle K. Manske, Vivekananda Sarangi, Matthew J. Maurer +16 more

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Blood(2024)10.1182/blood.2024025681

N/A

0DataRank · unranked

5 citations

Matthew J. Maurer, Thomas M. Habermann, Richard Burack, Jennifer R. Chapman, Jonathon B. Cohen +18 more

Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models

Journal of Gynecologic Oncology(2024)10.3802/jgo.2025.36.e4

N/A

0DataRank · unranked

2 citations

Xiaonan Hou, Jennifer Veneris, N Kazi, Melissa C. Larson, Matthew J. Maurer +8 more

Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study

American Journal of Hematology(2025)10.1002/ajh.27630

N/A

0DataRank · unranked

10 citations

Jean L. Koff, Melissa C. Larson, Brad S. Kahl, Carla Casulo, Izidore S. Lossos +25 more

Risk of lymphoid malignancy associated with cancer predisposition genes

Blood Cancer Journal(2025)10.1038/s41408-025-01283-z

N/A

0DataRank · unranked

8 citations

Raphael Mwangi, Dennis P. Robinson, Cristine Allmer, Allison Rosenthal, Thomas M. Habermann +95 more

Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma

Journal of Experimental & Clinical Cancer Research(2025)10.1186/s13046-025-03406-7

N/A

0DataRank · unranked

1 citations

Valentina Zanfagnin, Conway Xu, Erik Jessen, Yuanhang Liu, Chen Wang +17 more

Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity

Experimental Hematology and Oncology(2025)10.1186/s40164-025-00681-0

N/A

0DataRank · unranked

1 citations

Jill M. Wagner, Arun Kanakkanthara, Annapoorna Venkatachalam, Aaron M Deisinger, Cristina Correia +18 more

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

Journal of Clinical Oncology(2025)10.1200/jco-25-00892

N/A

0DataRank · unranked

1 citations

Vít Procházka, Tarec Christoffer El‐Galaly, Christopher R. Flowers, Diego Villa, Emmanuel Bachy +43 more

Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of Origin

Cancer Epidemiology Biomarkers & Prevention(2025)10.1158/1055-9965.epi-24-1610

N/A

0DataRank · unranked

0 citations

Dennis P. Robinson, Lisa M. Rimsza, Melissa C. Larson, Rebecca L. King, Grzegorz S. Nowakowski +9 more

271 | LEUKEMIC NON‐NODAL MANTLE CELL LYMPHOMA IS NOT NECESSARILY EQUIVALENT TO INDOLENT MCL: A REPORT FROM THE LEO COHORT STUDY

Hematological Oncology(2025)10.1002/hon.70094_271

N/A

0DataRank · unranked

0 citations

Yihua Chen, Jeffrey M. Switchenko, Suheil Albert Atallah‐Yunes, Georgio Pongas, Mary P. Watkins +16 more

29 | A COMPARATIVE ANALYSIS OF HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA AT DIAGNOSIS (COMPOSITE LYMPHOMA) AND SEQUENTIALLY TRANSFORMED FOLLICULAR LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70093_29

N/A

0DataRank · unranked

0 citations

Melissa C. Larson, Jonathan Day, Urshila Durani, Mazie Tsang, Dai Chihara +22 more

Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies MMP16 and KCTD15 as risk loci

medRxiv(2025)10.64898/2025.12.16.25342433

N/A

0DataRank · unranked

0 citations

Milagros Pereyra, Mohammed Tiseer Abbas, Reza Arsanjani, Isaac Prah, Nicholas Boddicker +16 more

Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer

European Urology(2020)10.1016/j.eururo.2020.07.038

N/A

0DataRank · unranked

42 citations

Shannon K. McDonnell, Liesel M. FitzGerald, Lissa DeRycke, Zachary C. Fogarty, Graham G. Giles +34 more

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

Blood Cancer Journal(2020)10.1038/s41408-020-00382-3

N/A

0DataRank · unranked

31 citations

Kerstin Wenzl, Keenan T. Hartert, Michelle K. Manske, Vivekananda Sarangi, Matthew J. Maurer +10 more

Prognostic relevance of CD4+ T-cells in the microenvironment of newly diagnosed follicular lymphoma (FL) patients is independent of the tumor gene expression profile.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8052

N/A

0DataRank · unranked

1 citations

Angelo Famà, Melissa C. Larson, Andew L. Feldman, Zhi-Zhang Yang, José C. Villasboas +13 more

Melissa C. Larson

Indexed papers

Top data-sharing exemplar

Papers